Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2026-02-22 @ 4:53 PM
Study NCT ID:
NCT06239532
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-21
First Post:
2023-12-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Qilu Hospital of Shandong University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Intrahepatic Cholangiocarcinoma | View |
Keywords: